Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns

Name: Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns
Published: 2025
License: Public Domain

Belfast Health and Social Care Trust · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

vegf

severe diabetic macular oedema, diabetic macular oedema, anti-vegf, subthreshold micropulse laser, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns

Related documents